After the virologic failure of cabotegravir/rilpivirine and despite dual-class resistance mutations, Canadian doctors have had surprising success with a single pill of the integrase inhibitor bictegravir.

The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV infection. The recommendation, issued at the International AIDS Conference in Kigali,

The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, lenacapavir, as a tool in their efforts to fight HIV infections – especially for groups most at risk and in areas where the burden of HIV remains high.

Newborns exposed to HIV during pregnancy or birth should receive preventive antiretroviral medication immediately after delivery to reduce the risk of transmission from mother to child.

ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with the Medicines Patent Pool to allow generic production of its long-acting injectable HIV treatment cabotegravir.

Jigawa State Agency for the Control of AIDS (JISACA) has targeted to eliminate HIV/AIDS by the year 2030. The agency’s manager, Ibrahim Almajiri, stated

Freda Jones, founder of LOTUS, empowers women living with HIV in Atlanta through a peer-led support group. Peer support is crucial for HIV care.

State attorneys general and federal prosecutors alleged Gilead Sciences illegally bankrolled lavish events for prescribers.

Pharma giant Gilead Sciences agreed to pay hundreds of millions of dollars to state health insurance programs after admitting to a years-long kickback scheme to promote its panel of HIV medications. The California-based drug company reached a $202 million settlement with a coalition of 49 states led by New York for incentivizing doctors to prescribe its HIV meds with hundreds of thousands of dollars in payments,